Ensysce Biosciences
ENSC
18 hedge funds and large institutions have $261K invested in Ensysce Biosciences in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
20% more funds holding
Funds holding: 15 → 18 (+3)
0% less capital invested
Capital invested by funds: $261K → $261K (-$430)
7.52% less ownership
Funds ownership: 13.41% → 5.89% (-7.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$70.5K |
| 2 |
VF
Virtu Financial
New York
|
+$29.6K |
| 3 |
HF
HRT Financial
New York
|
+$19.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$12.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.73K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.22K |
ENSC Hedge Fund Activity: Q2 2026 in Review
18 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q2 2026, worth a combined $261K — down 0.16% from $261K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ENSC positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $70.5K. The largest seller was Vanguard Fiduciary Trust, exiting entirely with an estimated $12.9K sold.
- 18 institutional investors held Ensysce Biosciences (ENSC) as of Q2 2026, up from 15 in Q1 2026.
- Funds reported $261K of Ensysce Biosciences stock for Q2 2026, down 0.16% quarter-over-quarter.
- 5 funds opened new Ensysce Biosciences positions in Q2 2026 and 2 closed out, a net change of +3 holders.
- The largest Ensysce Biosciences buyer in Q2 2026 was Jane Street, an estimated $70.5K added.
- The largest Ensysce Biosciences seller in Q2 2026 was Vanguard Fiduciary Trust, an estimated $12.9K sold.
Based on aggregated 13F filings for Q2 2026.